Citadel Advisors
ACHV icon

Citadel Advisors’s Achieve Life Sciences ACHV Stock Holding History

Citadel Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
203,100
+300
+0.1% +$1.43K ﹤0.01% 7510
2026
Q1 		$596K Buy
202,800
+108,900
+116% +$484K ﹤0.01% 8864
2025
Q4 		$467K Buy
93,900
+69,700
+288% +$304K ﹤0.01% 9190
2025
Q3 		$76.2K Buy
+24,200
New +$66.4K ﹤0.01% 12002
2025
Q2 		– Sell
-11,800
Closed -$31.5K – 12317
2025
Q1 		$31.5K Buy
11,800
+7,600
+181% +$23.6K ﹤0.01% 12772
2024
Q4 		$14.8K Sell
4,200
-18,400
-81% -$83.4K ﹤0.01% 13391
2024
Q3 		$107K Sell
22,600
-42,400
-65% -$194K ﹤0.01% 11017
2024
Q2 		$306K Buy
65,000
+36,000
+124% +$173K ﹤0.01% 9098
2024
Q1 		$132K Buy
+29,000
New +$129K ﹤0.01% 10960
2023
Q4 		– Sell
-3,800
Closed -$16.3K – 14167
2023
Q3 		$16.3K Sell
3,800
-23,400
-86% -$118K ﹤0.01% 12781
2023
Q2 		$141K Sell
27,200
-8,700
-24% -$61K ﹤0.01% 10420
2023
Q1 		$244K Buy
35,900
+29,800
+489% +$142K ﹤0.01% 9808
2022
Q4 		$15.1K Buy
+6,100
New +$15.7K ﹤0.01% 13353
2022
Q3 		– Sell
-13,000
Closed -$63K – 12487
2022
Q2 		$63K Sell
13,000
-37,200
-74% -$252K ﹤0.01% 11774
2022
Q1 		$380K Buy
+50,200
New +$374K ﹤0.01% 10036

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Citadel Advisors's ACHV Position: Q2 2026 in Review

Citadel Advisors opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 123,129 shares worth $804K. The stake represents ﹤0.01% of the portfolio and ranks #8750 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in ACHV as recently as Q2 2025.

Citadel Advisors first reported a position in ACHV in Q1 2015 and has held it in 23 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Citadel Advisors held 123,129 shares of Achieve Life Sciences worth $804K as of Q2 2026.
  • Achieve Life Sciences was a new Citadel Advisors position in Q2 2026.
  • Achieve Life Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8750 holding.
  • Citadel Advisors first reported a position in Achieve Life Sciences in Q1 2015 and has held it in 23 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.